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B!" 1. N!#-HLA $%#%& '&&!()'*%+ ,)*- CD 
Candidate gene association study: Candidate genes, selected on the basis of current understanding 
of CD immunopathology, were tested for association with CD. Genes studied with this approach 
include, among others, IFN-!, FAS, TCR, and TG255. No convincing association with CD was found.
Genetic linkage study: "is approach is aimed at the identi#cation of chromosomal regions that likely 
contain disease-causing genes in families with a high prevalence of CD.  "e genomic region 2q33 showed 
linkage to CD in multiple populations. "is region contains the genes CD28, CTLA4 and ICOS which 
all control di$erent aspects of the T cell response55. Linkage was also found for chromosome 5q31-3356 and 
chromosome 19p13.157. Linkage to these regions, however, could not always be replicated in other populations. 
Genome-wide association study (GWAS): In recent years it has become possible to perform large-scale case 
control-based association studies using single nucleotide polymorphisms (SNPs). With this approach it is possible 
to identify common variants in the genome that predispose to disease. Until now, 10 non-HLA loci associated 
with CD have been identi#ed and linkage to 2q33 has been con#rmed (Table 1)28;58;59. Recently, 13 additional 
true risk variants and 13 suggestive risk variants were identi#ed60. Although causality has only been proven for 



















IL-15 is a cytokine that, just as IL-2, is able to induce T cell proliferation, IFN-! production and cytotoxicity. Furthermore, IL-
15 is known to play an important role in NK cell development and activation62. Under normal circumstances, IL-15 expression 
is strictly regulated at the level of transcription, translation and secretion63. In CD this regulation is disrupted, which results 
in massive upregulation of IL-15 in the epithelium and lamina propria. "e abnormal availability of IL-15 results in chronic 
in%ammation by survival, proliferation and activation of IELs64;65.  Furthermore, IL-15 can exert an inhibitory e$ect on TGF-&, 
a negative regulator of the immune response66. Recently it has been shown that IL-15 can synergize with IL-21, a cytokine 


























B!" 3. D).%(* %//%(*& !/ $01*%#
"e role of gluten in the adaptive immune response in CD is well established. In addition, a direct (innate) e$ect of gluten 
on the intestinal mucosa has been suggested. One of the #rst indications for the potential of gluten to elicit a response 
in the epithelium came from in vivo challenges where administration of gliadin caused villous atrophy and increase 
of IELs within 2-3 hours a'er gluten ingestion69. "is e$ect was later attributed to the non-immunodominant peptide 
p31-49 from alpha-gliadin70. In vitro studies with p31-49 showed that epithelial alterations were independent of CD4+ 
T cell activation. Furthermore, p31-49 stimulated IL-15 production in the lamina propria of cultured biopsies from CD 
patients71. "e fact that p31-49 could activate the local immune system implied that a receptor for p31-49 should exist.  A 
transcellular transport pathway was proposed where anti-gliadin IgA antibodies were able to bind p31-49. "is complex 
would then bind the transferrin receptor CD71 which would provide protected tra(cking across the intestinal epithelium51. 
However, this mechanism would not function in all CD patients as a relatively large fraction of them is IgA de#cient72.
We also assessed the hypothesis that a receptor for p31-49 is present on intestinal epithelial cells. Binding of p31-49 to 
intestinal epithelial cell lines, however, could not be detected, neither directly nor by either UV-crosslinking or TG2 
induced transamidation (Tjon et al. unpublished data). In the absence of a receptor through which p31-43 could exert 
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 TCR-! TCR-" TCR-# Conclusion 
P1 - + + TCR-!: D-J rearrangement TCR-": non-functional V 
P2 + + - TCR-#: incomplete; TCR-": 1 out of frame, 1 non-functional V 
P3 - - - No rearrangements 
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CELL TYPE MARKER ANTIBODY CLONE NAME P1 P2 P3 P4 
Leucocyte CD11a  G43-25B         
Leucocyte CD18  L130         
Leucocyte CD54  LB-2         
Leucocyte CD62L SK11-EMPTY         
Leucocyte CD31 WM59         
Leucocyte CD52 Campath 1-H         
Leucocyte CD45 2D1         
Monocyte CD14 MEM-15         
Monocyte CD33 HIM3-4         
B (pre-B) CD10 ALB2         
B CD40 5C3         
B CD19 LT19         
T/B CD6 MT605         
T/B CD5 L17F12         
T/B/NK CD38 HB7         
T/B/NK CD30 BerH8         
T/B/NK CD45 RA L48         
T CD3 S4.1         
T/NK CD3 ic SK7         
T CD4 SK3         
T/NK CD8-! SK1         
T CD8-" 2ST8.5H7         
T CD45 RO UCHL1         
T CD152  BN13         
T CD154 TRAP1         
T CD44 G44-26         
T  CD28 CD28.2         
T/LTI CD127  ebioRDR5       40% 
T/NK CD2 S5.2         
T/NK CD25 M-A251         
T/NK CD27 M-T271         
T/NK CD7 6B7         
T/NK Integrin beta-7 F1B504         
IEL T/NK CD103 Ber-ACT8         
NK/T CD122  TU27         
NK/T IL15 R! 151303.         
NK/T CD56 MEM-188     2%   
NK/T CD161 DX12         
NK/T CD16 GO22         
NK/T CD226  DX11         
NK/T KIR2DL1/S1 EB6         
NK/T KIR2DL2/L3/S2 GL183         
NK/T KIR2DL4 181703.         
NK/T KIR2DL5 UP-R1         
NK/T KIR2DS2/L3 1F12         
NK/T KIR2DS4  FES172         
NK/T KIR3DL1 DX9         
NK/T KIR3DL2  Q66         
NK/T CD94 HP-3D9         
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